Fig 2. The Placebo-adjusted percent intra-group mean exercise improvements for rintatolimod: ITT population and the target subset comparisons to drugs approved for non-ME/CFS severe exertional fatigue.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.